Allopurinol, a drug approved for hyperuricemia, significantly slowed the progression of renal disease in patients with moderate chronic disease, a small randomized trial showed.

Allopurinol, a drug approved for hyperuricemia, significantly slowed the progression of renal disease in patients with moderate chronic disease, a small randomized trial showed. Read the full story >